Quick Takeaways
- Laurence W. Lytton filed SCHEDULE 13G for Aprea Therapeutics, Inc. Common Stock (APRE).
- Disclosed ownership: 9.9%.
- Date of event: 13 Nov 2025.
Laurence W. Lytton - 13 Nov 2025 SCHEDULE 13G Report for Aprea Therapeutics, Inc. Common Stock (APRE)
- Filing Manager
- Laurence W. Lytton
- Reporting Manager
- LYTTON LAURENCE W
- Symbol
- APRE
- Shares outstanding
- 6,887,242 shares
- Disclosed Ownership
- 681,837 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Nov 2025, 19:16:45 UTC
- Date of event
- 13 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Laurence W. Lytton disclosed 9.9% ownership in Aprea Therapeutics, Inc. Common Stock (APRE) on 13 Nov 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Nov 2025, 19:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| LYTTON LAURENCE W | 9.9% | 681,837 | 677,618 | 4,219 | /s/ Laurence W. Lytton | Reporting Person |